AOB Misses Estimates, Shares Sink

American Oriental Bioengineering(AOB Quote) said it missed analysts' quarterly expectations, sending shares in the red Monday morning.

While the company was only off by a penny, shares fell 12% to $4.80.

During the quarter, income declined 17% to $7.9 million or 11 cents a share, from $9.4 million, or 12 cents in the same quarter last year. Analysts expected earnings of 12 cents.

Revenues rose 19% to $46.1 million from $38.8 million.

Regardless, American Oriental remains one of the Chinese stocks to stick with, according to RealMoney.com. American Oriental focuses on both modern pharmaceuticals and traditional Chinese medicine, affording it a reliable pipeline.